Glycomics

Glycomics is the analytical mapping of the glycome, the complete set of sugar chains (glycans) produced by a cell or organism. It matters mainly for complex, cell-made biologic drugs such as therapeutic antibodies, not for synthetic research peptides or small-molecule chemicals made without living cells.

Glycomics testing supports biologic drug quality

Glycans are not read from a fixed genetic template like DNA. Laboratories therefore release them from proteins, separate them by liquid chromatography, and identify them by mass spectrometry, including the precise molecular mass of each sugar structure.

For biologic drugs, regulators treat correct glycosylation as part of expected quality testing and as Critical Quality Attributes (CQAs). Under frameworks such as ICH Q6B, this data helps show safety, efficacy, stability, purity, and batch-to-batch consistency, so each production cycle remains uniform.

Common misunderstandings regarding glycomics analysis

• A missing glycomics section is normal for synthetic research peptides and small-molecule chemicals because they are made without living cells.
• Glycoproteomics maps the specific attachment sites of sugars on proteins, not just the sugar chains themselves.
• Total sugar content assays measure only the bulk amount of sugar, not the identity of individual sugar structures.
• The Multi-Attribute Method (MAM) is a broader quality control approach that tracks multiple molecular attributes at once.

Sources

1. Mass Spectrometry Approaches to Glycomic and Glycoproteomic Analyses
2. Glycomics and Glycoproteomics - Essentials of Glycobiology - NCBI Bookshelf
3. Glycomic and glycoproteomic analysis of glycoproteins—a tutorial
4. Chapter 48 Glycomics
5. A novel method for rapid glycan profiling of therapeutic monoclonal antibodies | FDA
6. Glycomics using mass spectrometry
7. Glycomic analysis: an array of technologies - PMC
8. Regulatory Guidelines for the Analysis of Therapeutic Peptides and ...
9. Mass spectrometry in clinical glycomics: The path from biomarker identification to clinical implementation
10. Multidimensional high-performance liquid chromatography-mapping method for N-linked glycan analysis - Glycoscience Protocols (GlycoPODv2) - NCBI Bookshelf
11. Mass spectrometry-based multi-attribute method in protein therapeutics product quality monitoring and quality control - PMC
12. The Hitchhiker's guide to glycoproteomics
13. Shotgun Glycomics: A Microarray Strategy for Functional Glycomics - PMC
14. Glycosylation Shapes the Efficacy and Safety of Diverse Protein, Gene and Cell Therapies
15. Characterization of O-Glycosylation and N ... - PMC - NIH
16. Mass Spectrometry and the Emerging Field of Glycomics - PMC
17. Chapter 51 Glycomics and Glycoproteomics
18. Antibody Glycosylation: FDA requirements and Characterization